We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+4.76%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$5.32B
AUM Growth
+$155M
Cap. Flow
-$100M
Cap. Flow %
-1.89%
Top 10 Hldgs %
16.3%
Holding
739
New
50
Increased
312
Reduced
249
Closed
35

Top Buys

Rank Stock Value
1
K
Kellanova
K
+$31M
2
CL icon
Colgate-Palmolive
CL
+$20M
3
MRK icon
Merck
MRK
+$18.8M
4
GLW icon
Corning
GLW
+$18.5M
5
FFIV icon
F5
FFIV
+$17.2M

Top Sells

Rank Stock Value
1
PEP icon
PepsiCo
PEP
+$40.4M
2
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$38M
3
META icon
Meta Platforms (Facebook)
META
+$23.2M
4
ORCL icon
Oracle
ORCL
+$20.4M
5
MJN
Mead Johnson Nutrition Company
MJN
+$20.4M

Sector Composition

Rank Sector Weight
1 Healthcare 25.58%
2 Technology 13.62%
3 Financials 13.2%
4 Consumer Discretionary 9.51%
5 Industrials 7.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AVDL
526
DELISTED
Avadel Pharmaceuticals
AVDL
$1.22M 0.02%
111,000
– –
WCN
527
Waste Connections
WCN
$42.8B
$1.22M 0.02%
18,984
– –
STAA icon
528
STAAR Surgical
STAA
$1.16B
$1.22M 0.02%
113,000
+68,000
+151% +$665K
AZN icon
529
AstraZeneca
AZN
$263B
$1.22M 0.02%
17,840
– –
CIT
530
DELISTED
CIT Group Inc.
CIT
$1.21M 0.02%
24,799
– –
SIRI icon
531
SiriusXM
SIRI
$10B
$1.21M 0.02%
+22,044
New +$1.13M
XNCR icon
532
Xencor
XNCR
$1.44B
$1.2M 0.02%
57,000
-78,000
-58% -$1.75M
DOV icon
533
Dover
DOV
$27.2B
$1.2M 0.02%
18,481
+895
+5% +$58.4K
AORT icon
534
Artivion
AORT
$1.23B
$1.2M 0.02%
60,000
-15,000
-20% -$269K
TBPH icon
535
Theravance Biopharma
TBPH
$874M
$1.2M 0.02%
30,000
-40,000
-57% -$1.54M
HRB icon
536
H&R Block
HRB
$5.18B
$1.19M 0.02%
+38,547
New +$1.01M
IVZ icon
537
Invesco
IVZ
$13.3B
$1.19M 0.02%
33,806
+4,150
+14% +$135K
TCOM icon
538
Trip.com Group
TCOM
$27.5B
$1.19M 0.02%
22,000
– –
AVY icon
539
Avery Dennison
AVY
$12.3B
$1.18M 0.02%
13,314
-50,461
-79% -$4.22M
O icon
540
Realty Income
O
$61.2B
$1.17M 0.02%
21,898
+2,580
+13% +$143K
DLR icon
541
Digital Realty Trust
DLR
$73.7B
$1.15M 0.02%
10,183
-1,922
-16% -$220K
DLTR icon
542
Dollar Tree
DLTR
$23.1B
$1.13M 0.02%
16,187
+513
+3% +$39.6K
MKL icon
543
Markel Group
MKL
$25B
$1.11M 0.02%
1,136
+113
+11% +$110K
TAP icon
544
Molson Coors Class B
TAP
$7.68B
$1.11M 0.02%
12,804
+1,314
+11% +$122K
XEC
545
DELISTED
CIMAREX ENERGY CO
XEC
$1.1M 0.02%
11,737
+6,058
+107% +$667K
FRT icon
546
Federal Realty Investment Trust
FRT
$10.9B
$1.09M 0.02%
8,648
+1,319
+18% +$170K
EXPE icon
547
Expedia Group
EXPE
$31.2B
$1.09M 0.02%
7,331
– –
MNST icon
548
Monster Beverage
MNST
$91.4B
$1.09M 0.02%
43,792
– –
ELGX
549
DELISTED
Endologix Inc
ELGX
$1.07M 0.02%
22,000
– –
TDG icon
550
TransDigm Group
TDG
$69.2B
$1.06M 0.02%
3,960
– –
20 21
22
23 24

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q2 2017 Portfolio in Review

As of Q2 2017, Candriam SCA held 739 positions worth $5.32B, up 3% from $5.17B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Candriam SCA's Q2 2017 filing shows 50 new, 312 increased, 249 reduced and 35 closed positions. Its largest new stake was Raymond James Financial: 164,790 shares worth $8.81M. The largest sale was PepsiCo, an estimated $40.4M.

By sector, the portfolio is most concentrated in Healthcare at 26% of assets, up from 24% a quarter earlier, followed by Technology and Financials.

  • Candriam SCA's largest Q2 2017 buy was Raymond James Financial: 164,790 shares worth $8.81M.
  • Candriam SCA added most to Kellanova in Q2 2017, an estimated $31M increase.
  • Candriam SCA's biggest Q2 2017 reduction was PepsiCo, cutting an estimated $40.4M.
  • Candriam SCA fully exited Mead Johnson Nutrition Company in Q2 2017, selling an estimated $20.4M.
  • Candriam SCA's ten largest holdings make up 16% of its $5.32B portfolio in Q2 2017.
  • Candriam SCA opened 50 new positions and closed 35 in Q2 2017.
  • Candriam SCA's portfolio value rose 3% quarter-over-quarter to $5.32B.

Based on Candriam SCA's 13F filing for Q2 2017, filed 31 Jul 2017.